Fat distribution and hemostatic measures in obese children

American Journal of Clinical Nutrition

Volumn 67, Issue 6, 1998, Pages 1136-1140

  Ferguson, Michael A ^b   Gutin, Bernard ^a   Owens, Scott ^b   Litaker, Mark ^b   Tracy, Russell P ^b   Allison, Jerry ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NONE

Author keywords

Children; D dimer; Fibrinogen; Hemostatic factors; Obesity; PAI 1; Plasminogen activator inhibitor 1; Visceral adipose tissue

Indexed keywords

PLASMINOGEN ACTIVATOR;

ADIPOSE TISSUE; ARTICLE; BODY MASS; CHILD; DATA ANALYSIS; ETHNOLOGY; FAT INTAKE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MORBIDITY; MORTALITY; OBESITY; PREDICTION; REGRESSION ANALYSIS;

PIERINAE;

EID: 0031837526     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/67.6.1136     Document Type: Article

References (28)

1. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA 1987;258:1183-6.
2. Shimomura I, Funahashi T, Takahashi M, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996;2:800-3.
3. Panchenko E, Dobrovolsky A, Davletov K, et al. D-Dimer and fibrinolysis in patients with various degrees of atherosclerosis. Eur Heart J 1995;16:38-42.
4. Koenig W, Resch KL, Ernst E. Fibrinogen and cardiovascular risk. Prim Cardiol 1994;20:39-45.
5. Cigolini M, Targher G, Bergamo Andreis IA, Tonoli M, Agostino G, De Sandre G. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol 1996;16:368-74.
6. Meilahn EN, Cauley JA, Tracy RP, Macy EO, Gutai JP, Kuller LH. Association of sex hormones and adiposity with plasma concentrations of fibrinogen and PAI-1 in post-menopausal women. Am J Epidemiol 1996;143:159-66.
7. Targher G, Tonoli M, Agostino G, et al. Ultrasonographic intra-abdominal depth and its relation to haemostatic factors in healthy males. Int J Obes 1996;20:882-5.
8. Vague P, Juhan-Vague I, Chabert V, Alessi MC, Allan C. Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women. Metabolism 1989;9:913-5.
9. Kortelainen ML, Särkioja T. Extent and composition of coronary lesions and degree of cardiac hypertrophy in relation to abdominal fatness in men under 40 years of age. Arterioscier Thromb Vase Biol 1997;17:574-9.
10. Bao W, Srinivasan SR, Berenson GS. Plasma fibrinogen and its correlates in children from a biracial community: the Bogalusa Heart Study. Pediatr Res 1993;33:323-6.
11. Legnani C, Maccaferri M, Tonini P, Cassio A, Cacciari E, Coccheri S. Reduced fibrinolytic response in obese children: association with high baseline activity of the fast acting plasminogen activator inhibitor (PAM). Fibrinolysis 1988;2:211-4.
12. Berenson GS, Wattigney WA, Tracy RE, et al. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am J Cardiol 1992;70:851-8.
13. Schneider DJ, Sobel BE. Augmentation of synthesis of plasminogen activator inhibitor type-1 by insulin and insulin-like growth factor type-1: implications for vascular disease in hyperinsulinemic states. Proc Natl Acad Sci U S A 1991;88:9959-63.
14. Must A, Dallal GE, Dietz WH. Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness. Am J Clin Nutr 1991;53:839-46.
15. Gutin B, Litaker M, Islam S, Manos T, Smith C, Treiber F. Body-composition measurement in 9-11-y-old children by dual-energy X-ray absorptiometry, skinfold-thickness measurements, and bioimpedance analysis. Am J Clin Nutr 1996;63:287-92.
16. Owens S, Gutin B, Karp W, Ferguson M, Moorehead S, Allison J. Relationship of total and visceral adipose tissue to cardiovascular health. In: Armstrong N, Kirby B, Welsman J, eds. Children and exercise. Vol 19. London: Chapman-Hall, 1997:373-81.
17. Sallis JF, Buono MJ, Roby JJ, Micale FG, Nelson JA. Seven day recall and other physical activity self-reports in children and adolescents. Med Sci Sports Exerc 1993;25:99-108
18. Anonymous. Clinical guide to laboratory tests. Philadelphia: WB Saunders, 1990.
19. Seljeflot I, Entstand J, Anderson P, Arnesen H. Global fibrinolytic capacity assessed by the serum 〈H〉d〈H〉-dimer test. Correlation between basal and stimulated values. Thromb Res 1994;75:157-62.
20. Geftken DF, Keating FG, Kennedy MH, Cornell ES, Bovill EG, Tracy RPI. The measurement of fibrinogen in population-based research: studies on instrumentation and methodology. Arch Pathol Lab Med 1994;118:1106-9.
21. Clauss VA. Gerrinnungs-physiologische schnell-methode zur bestimmung des fibrinogens. (Quick method to estimate fibrinogen by a functional clotting assay.) Acta Haematol 1957;17:237-46 (in German).
22. DeClerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 (PAI-1) in biological fluids with a murine monoclonal antibody based enzyme-linked immunosorbent assay. Blood 1988;71:220-5.
23. DeClerck PJ, Mombaerts P, Holvoet P, De Mol M, Collen D. Fibrinolytic response and fibrin fragment 〈H〉d〈H〉-dimer concentrations in patients with deep vein thrombosis. Thromb Haemost 1987;58:1024-9.
24. Sanchez-Bayle M, Cocho P, Baeza J, Vila S. Fibrinogen as cardiovascular risk factor in Spanish children and adolescents. Am Heart J 1993;126:322-6.
25. Sawdey MS, Lockutoff DJ. Regulation of murine type I plasminogen activator by inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor alpha and transforming growth factor beta. J Clin Invest 1994;88:1346-51.
26. Marongiu F, Conti M, Mameli G, et al. Is the imbalance between thrombin and plasmin activity in diabetes related to the concentrations of antiplasmin activity? Thromb Res 1990;58:91-9.
27. Fowkes FGR, Lowe GDO, Housley E, et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993;342:84-6.
28. Ridker PM, Hennekens CH, Cerkus A, Stampfer MJ. Plasma concentration of cross-linked fibrin degradation product (〈H〉d〈H〉dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 1994;90:2236-40.